methionine has been researched along with tobramycin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Dougherty, TJ; Fraimow, HS; Greenman, JB; Leviton, IM; Miller, MH | 1 |
Cantin, A; Woods, DE | 1 |
Campbell, KC; Cooper, MD; Fox, DJ; Hargrove, TL; Meech, RP; Roberts, MH; Rybak, LP; Speil, CA; Verhulst, SJ; Yanik, SC | 1 |
4 other study(ies) available for methionine and tobramycin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Tobramycin uptake in Escherichia coli is driven by either electrical potential or ATP.
Topics: Adenosine Triphosphate; Arsenates; Biological Transport, Active; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cell Division; Cell Movement; Cell Survival; Escherichia coli; Membrane Potentials; Methionine; Microscopy, Phase-Contrast; Onium Compounds; Organophosphorus Compounds; Proline; Tobramycin | 1991 |
Protection by antibiotics against myeloperoxidase-dependent cytotoxicity to lung epithelial cells in vitro.
Topics: Animals; Anti-Bacterial Agents; Catalase; Cats; Ceftazidime; Cell Survival; Dose-Response Relationship, Drug; Epithelial Cells; Epithelium; Gentamicins; Glutathione; Granulocytes; Humans; Kinetics; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung; Methionine; Peroxidase; Sodium Hypochlorite; Structure-Activity Relationship; Ticarcillin; Tobramycin | 1993 |
d-Methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models.
Topics: Animals; Anti-Infective Agents; Cystic Fibrosis; Drug Monitoring; Ear Diseases; Escherichia coli; Evoked Potentials, Auditory, Brain Stem; Guinea Pigs; Hair Cells, Auditory, Outer; Methionine; Mice; Protective Agents; Tobramycin | 2016 |